{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:06:09Z","timestamp":1785539169659,"version":"3.56.0"},"reference-count":210,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.gastrohep.2025.502529","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T12:34:10Z","timestamp":1752582850000},"page":"502529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Documento de posicionamiento de GETECCU sobre fragilidad, edad avanzada y enfermedad inflamatoria intestinal"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9051-2581","authenticated-orcid":false,"given":"M\u00edriam","family":"Ma\u00f1osa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margalida","family":"Calafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Francia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Riba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Mesonero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Garc\u00eda-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Losfablos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Calvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugeni","family":"Dom\u00e8nech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Guti\u00e9rrez Casbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Ord\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Mench\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Rodr\u00edguez-Moranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamile","family":"Zabana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2025.502529_bib1000","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/ibd\/izad182","article-title":"Inflammatory Bowel Diseases-related Disability: Risk Factors, Outcomes, and Interventions","volume":"30","author":"Tse","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1005","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/ibd\/izx100","article-title":"Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I","volume":"24","author":"Knowles","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1010","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/apt.18390","article-title":"Meta-Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Diseases","volume":"61","author":"Carbery","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1015","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/ibd\/izab039","article-title":"Aging and IBD: A New Challenge for Clinicians and Researchers","volume":"28","author":"Faye","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1020","article-title":"Diccionario de la lengua espa\u00f1ola","year":"2014","journal-title":"Real Academia Espa\u00f1ola, vig\u00e9simotercera edici\u00f3n"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ageing\/26.4.315","article-title":"Unstable disability and the fluctuations of frailty","volume":"26","author":"Campbell","year":"1997","journal-title":"Age Ageing"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1030","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: Evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1035","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40985-016-0021-8","article-title":"Screening for frailty: Older populations and older individuals","volume":"37","author":"Santos-Eggimann","year":"2016","journal-title":"Public Health Rev"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1045","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1159\/000528561","article-title":"Frailty: Pathophysiology, theoretical and operational definition (s), impact, prevalence, management and prevention, in an increasingly economically developed and ageing world","volume":"69","author":"Doody","year":"2023","journal-title":"Gerontology"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1050","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3390\/jcm13030721","article-title":"To be frail or not to be frail: This is the Question. A critical narrative review of frailty","volume":"13","author":"Siacchitano","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1055","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","article-title":"Frailty: Implications for clinical practice and public health","volume":"394","author":"Hoogendijk","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1060","first-page":"226","article-title":"Prevalence of frailty at population level in European ADVANTAGE Joint Action Member States: A systematic review and meta-analyisis","volume":"54","author":"\u00d3Caoimh","year":"2018","journal-title":"Ann Ist Super Sanita"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1065","first-page":"77","article-title":"Actualizaci\u00f3n en valoraci\u00f3n geri\u00e1trica integral","volume":"137","author":"S\u00e1nchez Garc\u00eda","year":"2020","journal-title":"Anales de la Real Academia Nacional de Medicina"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1070","doi-asserted-by":"crossref","first-page":"101483","DOI":"10.1016\/j.regg.2024.101483","article-title":"Fragilidad y capacidad intr\u00ednseca; del concepto te\u00f3rico a la aplicabilidad cl\u00ednica","volume":"59","author":"P\u00e9rez-Castej\u00f3n","year":"2024","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1075","first-page":"29","article-title":"La fragilidad, una perspectiva a lo largo del tiempo","volume":"95","author":"Rodr\u00edguez Ma\u00f1as","year":"2021","journal-title":"Rev Esp Salud Publica"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1080","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/gerona\/62.7.722","article-title":"Frailty in relation to the accumulation of deficits","volume":"62","author":"Rockwood","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12877-018-0718-2","article-title":"Frail-VIG index: A concise frailty evaluation tool for rapid geriatric assessment","volume":"18","author":"Ambl\u00e0s-Novellas","year":"2018","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1090","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5770\/cgj.23.463","article-title":"Using the clinical frailty scale in allocating scarce health care resources","volume":"23","author":"Rockwood","year":"2020","journal-title":"Can Geriatr J"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1095","unstructured":"Frailty Science Scale (CFS). App store. Disponible en: https:\/\/apps.apple.com\/gb\/app\/clinical-frailty-scale-cfs\/id1508556286. Google play store. https:\/\/play.google.com\/store\/apps\/details?id=com.clinicalfrailtyscle&hl=es [consultado 20 Jun 2025]."},{"key":"10.1016\/j.gastrohep.2025.502529_bib1100","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1110","first-page":"263","article-title":"European Crohn's and Colitis Organisation Topical Review on IBD in the Elderly","volume":"11","author":"Sturm","year":"2017","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1115","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.dld.2022.12.024","article-title":"Management of inflammatory bowel disease in the elderly: A review","volume":"55","author":"Sousa","year":"2023","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1120","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/ageing\/17.6.410","article-title":"Does ulcerative colitis behave differently in the elderly?","volume":"17","author":"Jones","year":"1988","journal-title":"Age Ageing"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1125","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0016-5085(98)70421-4","article-title":"Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival","volume":"114","author":"Loftus","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1130","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ibd.20029","article-title":"Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000","volume":"13","author":"Loftus","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1135","first-page":"157","article-title":"Epidemiology of inflammatory bowel diseases in the elderly in the province of Li\u00e8ge","volume":"26","author":"Piront","year":"2002","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1140","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1053\/j.gastro.2022.07.062","article-title":"The Rising Burden of Inflammatory Bowel Disease in Denmark Over Two Decades: A Nationwide Cohort Study","volume":"163","author":"Agrawal","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1145","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1053\/j.gastro.2019.01.002","article-title":"Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data","volume":"156","author":"Coward","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1150","first-page":"410","article-title":"Incidence of inflammatory bowel disease in the area of Li\u00e8ge: A 3 years prospective study (1993-1996)","volume":"61","author":"Latour","year":"1998","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1155","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.crohns.2014.03.006","article-title":"The incidence of ulcerative colitis (1995-2011) and Crohn's disease (1995-2012) - based on nationwide Danish registry data","volume":"8","author":"N\u00f8rg\u00e5rd","year":"2014","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1160","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3748\/wjg.v12.i1.75","article-title":"Crohn's disease in Stockholm County during 1990-2001: An epidemiological update","volume":"12","author":"Lapidus","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1165","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.crohns.2010.08.004","article-title":"IBD in the elderly population: Results from a population-based study in Western Hungary, 1977-2008","volume":"5","author":"Lakatos","year":"2011","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1170","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/gutjnl-2012-303864","article-title":"Natural history of elderly-onset inflammatory bowel disease: A population-based cohort study","volume":"63","author":"Charpentier","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1175","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/ecco-jcc\/jjac177","article-title":"Increasing Incidence of Inflammatory Bowel Disease, with Greatest Change Among the Elderly: A Nationwide Study in Finland, 2000-2020","volume":"17","author":"Kontola","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1180","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/MIB.0000000000000738","article-title":"Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age-An Increasing Distinct Entity?","volume":"22","author":"Jeuring","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1185","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1093\/ibd\/izz092","article-title":"Comparative Incidence of Inflammatory Bowel Disease in Different Age Groups in the United States","volume":"25","author":"Keyashian","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1190","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/ecco-jcc\/jjaa181","article-title":"Epidemiology and Natural History of Elderly-onset Inflammatory Bowel Disease: Results From a Territory-wide Hong Kong IBD Registry","volume":"15","author":"Mak","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1195","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.3390\/jcm12155142","article-title":"Global Epidemiology and Burden of Elderly-Onset Inflammatory Bowel Disease: A Decade in Review","volume":"12","author":"Danpanichkul","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1200","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/apt.14494","article-title":"Phenotype and natural history of elderly onset inflammatory bowel disease: A multicentre, case-control study","volume":"47","author":"Ma\u00f1osa","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1205","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/ecco-jcc\/jjw054","article-title":"Systematic Review and Meta-analysis: Phenotype and Clinical Outcomes of Older-onset Inflammatory Bowel Disease","volume":"10","author":"Ananthakrishnan","year":"2016","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1210","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.cgh.2020.02.048","article-title":"Progression of Elderly Onset Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Population-Based Cohort Studies","volume":"18","author":"Rozich","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1215","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000509544","article-title":"Malignancies in Inflammatory Bowel Disease","volume":"101","author":"Greuter","year":"2020","journal-title":"Digestion"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1220","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/gut.40.2.228","article-title":"Reduced bone density in patients with inflammatory bowel disease","volume":"40","author":"Bjarnason","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1225","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/gut.2003.026799","article-title":"Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: A population based cohort study","volume":"53","author":"Card","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1230","doi-asserted-by":"crossref","first-page":"496","DOI":"10.5217\/ir.2019.00050","article-title":"Polypharmacy is a risk factor for disease flare in adult patients with ulcerative colitis: A retrospective cohort study","volume":"17","author":"Wang","year":"2019","journal-title":"Intest Res"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1235","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/gutjnl-2017-315666","article-title":"Inflammatory bowel disease increases the risk of Parkinson's disease: A Danish nationwide cohort study 1977-2014","volume":"68","author":"Villumsen","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1240","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/gutjnl-2020-320789","article-title":"Inflammatory bowel disease is associated with higher dementia risk: A nationwide longitudinal study","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2025.502529_bib1245","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1111\/j.1582-4934.2009.00733.x","article-title":"Inflammation and frailty measures in older people","volume":"13","author":"Hubbard","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1250","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.annepidem.2023.10.006","article-title":"Frailty and pre- frailty with long-term risk of elderly-onset inflammatory bowel disease: A large-scale prospective cohort study","volume":"88","author":"Zhang","year":"2023","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1255","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.3390\/jcm12072658","article-title":"Reversibility of Frail Phenotype in Patients with Inflammatory Bowel Diseases","volume":"12","author":"Salvatori","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1260","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/apt.15821","article-title":"Frailty is independently associated with mortality in 11 001 patients with inflammatory bowel diseases","volume":"52","author":"Kochar","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1265","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s12876-022-02620-3","article-title":"Prevalence of frailty among patients with inflammatory bowel disease and its association with clinical outcomes: A systematic review and meta-analysis","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1270","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jss.2015.04.014","article-title":"Outcomes after ileoanal pouch surgery in frail and older adults","volume":"198","author":"Cohan","year":"2015","journal-title":"J Surg Res"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1275","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/000313481808400229","article-title":"Frailty Predicts Morbidity after Colectomy for Ulcerative Colitis","volume":"84","author":"Telemi","year":"2018","journal-title":"Am Surg"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1280","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1053\/j.gastro.2020.02.032","article-title":"Pretreatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients With Inflammatory Bowel Diseases","volume":"158","author":"Kochar","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1285","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S2468-1253(22)00358-2","article-title":"Management of inflammatory bowel diseases in older adults","volume":"8","author":"Singh","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1290","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/ecco-jcc\/jjad175","article-title":"Frailty Screening is Associated with Hospitalization and Decline in Quality of Life and Functional Status in Older Patients with Inflammatory Bowel Disease","volume":"18","author":"Asscher","year":"2024","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1295","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/ibd\/izac242","article-title":"Frail Phenotype in Patients With Inflammatory Bowel Disease","volume":"29","author":"Salvatori","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1300","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s10620-021-06990-8","article-title":"Inflammatory Bowel Disease Patients Who Respond to Treatment with Anti-tumor Necrosis Factor Agents Demonstrate Improvement in Pre-treatment Frailty","volume":"67","author":"Kochar","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1310","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1315","doi-asserted-by":"crossref","first-page":"e1006","DOI":"10.1016\/j.cgh.2021.06.015","article-title":"Deficits in Geriatric Assessment Associate With Disease Activity and Burden in Older Patients With Inflammatory Bowel Disease","volume":"20","author":"Asscher","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1320","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11894-019-0720-7","article-title":"IBD in the Elderly: Management Challenges and Therapeutic Considerations","volume":"21","author":"Tran","year":"2019","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1325","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1016\/S2666-7568(22)00060-5","article-title":"Is it time to include older adults in inflammatory bowel disease trials? A call for action","volume":"3","author":"Vieujean","year":"2022","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1330","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/MCG.0000000000001557","article-title":"Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBD","volume":"56","author":"Barnes","year":"2022","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1335","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40001-022-00687-y","article-title":"5-ASA induced interstitial nephritis in patients with inflammatory bowel disease: A systematic review","volume":"27","author":"Moss","year":"2022","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1340","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/apt.15408","article-title":"No increased risk of nephrotoxicity associated with 5-aminosalicylic acid in IBD: A population-based cohort and nested case-control study","volume":"50","author":"Jairath","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1345","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ecco-jcc\/jjv059","article-title":"Inflammatory bowel disease and the elderly: A review","volume":"9","author":"Taleban","year":"2015","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1350","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cger.2020.08.006","article-title":"Fecal Incontinence in the Elderly","volume":"37","author":"Pasricha","year":"2021","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1355","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1007\/s10620-012-2083-x","article-title":"Geriatric inflammatory bowel disease: Phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity","volume":"57","author":"Juneja","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1360","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/MIB.0000000000000747","article-title":"Medication utilization and the impact of continued corticosteroid use on patient-reported outcomes in older patients with inflammatory bowel disease","volume":"22","author":"Geisz","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1365","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/ajg.2014.313","article-title":"Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel diseases","volume":"109","author":"Brassard","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1370","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.crohns.2012.12.008","article-title":"Health care for osteoporosis in inflammatory bowel disease: Unmet needs in care of male patients?","volume":"7","author":"Walldorf","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1375","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/j.1572-0241.2006.00571.x","article-title":"Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in inflammatory bowel disease (IBD) patients who meet the guidelines\u2019 criteria","volume":"101","author":"Kornbluth","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1380","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1007\/s10620-020-06427-8","article-title":"Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy","volume":"66","author":"Balram","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1385","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/gutjnl-2019-320185","article-title":"Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn's disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource","volume":"70","author":"Stournaras","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1390","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/apt.15458","article-title":"Increased risk of thiopurine-related adverse events in elderly patients with IBD","volume":"50","author":"Calafat","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1395","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1136\/gutjnl-2013-305763","article-title":"Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer","volume":"63","author":"Beaugerie","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1400","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/apt.13466","article-title":"Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: A prospective observational cohort study","volume":"43","author":"Bourrier","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1405","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/aje\/kws375","article-title":"Use of azathioprine and the risk of cancer in inflammatory bowel disease","volume":"177","author":"Pasternak","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1410","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1053\/j.gastro.2013.07.035","article-title":"Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: A nationwide retrospective cohort study","volume":"145","author":"Khan","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1415","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/apt.13294","article-title":"Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease","volume":"42","author":"Lobat\u00f3n","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1420","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cgh.2020.04.070","article-title":"Safety and Efficacy of Tumor Necrosis Factor Antagonists in Older Patients With Ulcerative Colitis: Patient-Level Pooled Analysis of Data From Randomized Trials","volume":"19","author":"Cheng","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1430","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/ecco-jcc\/jjaa012","article-title":"Increased Discontinuation Rates of Anti-TNF Therapy in Elderly Inflammatory Bowel Disease Patients","volume":"14","author":"de Jong","year":"2020","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1435","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cgh.2010.09.026","article-title":"Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease","volume":"9","author":"Cottone","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1440","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1007\/s00384-020-03716-6","article-title":"Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse events","volume":"35","author":"Asscher","year":"2020","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1445","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ibd.21771","article-title":"Can elderly people be treated safely with anti-TNF agents?","volume":"18","author":"Billioud","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1450","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/apt.16060","article-title":"Long-term safety of vedolizumab for inflammatory bowel disease","volume":"52","author":"Loftus","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1455","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.3390\/jcm11154422","article-title":"Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis","volume":"11","author":"Hahn","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1460","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.3748\/wjg.v28.i33.4823","article-title":"Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective study","volume":"28","author":"Hahn","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1465","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/apt.15177","article-title":"Comparative safety and effectiveness of tumor necrosis factor \u03b1 antagonists and vedolizumab in elderly IBD patients: A multicentre study","volume":"49","author":"Adar","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1470","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/14740338.2019.1612874","article-title":"Safety of drugs used for the treatment of Crohn's disease","volume":"18","author":"Pudipeddi","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1475","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s10620-022-07770-8","article-title":"Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn's Disease Patients","volume":"68","author":"Gebeyehu","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1480","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/MEG.0000000000002436","article-title":"Safety and effectiveness of ustekinumab in elderly Crohn's disease patients","volume":"34","author":"Fiske","year":"2022","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1485","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/ecco-jcc\/jjac108","article-title":"Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry","volume":"17","author":"Casas-Deza","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1490","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(22)00467-6","article-title":"Risankizumab as induction therapy for Crohn's disease: Results from the phase 3 ADVANCE and MOTIVATE induction trials","volume":"399","author":"D\u2019Haens","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1495","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(22)00466-4","article-title":"Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: Results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial","volume":"399","author":"Ferrante","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1500","unstructured":"Skyrizi US Package Insert. Disponible en: https:\/\/www.rxabbvie.com\/pdf\/skyrizi_pi.pdf [consultado 20 Jun 2025]."},{"key":"10.1016\/j.gastrohep.2025.502529_bib1505","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/17474124.2020.1785868","article-title":"PK, PD and interactions: The new scenario with JAK inhibitors and S1P receptor modulators, two classes of small molecule drugs, in IBD","volume":"14","author":"Gilardi","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1510","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ibd\/izac084","article-title":"Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program","volume":"29","author":"Lichtenstein","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1515","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/apt.17674","article-title":"Integrated safety analysis of Filgotinib for ulcerative colitis: A post-hoc analysis from the SELECTION study","volume":"58","author":"Schreiber","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1520","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3390\/cells12131722","article-title":"Efficacy and Safety of Biological Therapies and JAK Inhibitors in Older Patients with Inflammatory Bowel Disease","volume":"12","author":"Fries","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1525","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1530","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/ard-2022-222259","article-title":"Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: A post hoc analysis from ORAL Surveillance","author":"Charles-Schoeman","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1535","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/17474124.2023.2194631","article-title":"Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: Systematic review and meta-analysis of randomized controlled trials","volume":"17","author":"Shehab","year":"2023","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1540","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1080\/14740338.2023.2223955","article-title":"Investigating the risk of deep vein thrombosis with JAK inhibitors: a disproportionality analysis using FDA Adverse Event Reporting System Database (FAERS)","volume":"22","author":"Mytheen","year":"2023","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1545","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1080\/14740338.2023.2223952","article-title":"Post-Marketing Safety Concerns with Upadacitinib: A Disproportionality Analysis of the FDA Adverse Event Reporting system","volume":"22","author":"Wu","year":"2023","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1550","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/ibd\/izac063","article-title":"Long-term Risk of Herpes Zoster Infection in Patients with Ulcerative Colitis Receiving Tofacitinib","volume":"29","author":"Winthrop","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1555","series-title":"Ministerio de Sanidad. Recomendaciones de vacunaci\u00f3n frente a herpes z\u00f3ster con vacuna recombinante (Shingrix\u00ae)","year":"2023"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1560","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1056\/NEJMoa2033617","article-title":"Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis","volume":"385","author":"Sandborn","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1565","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(23)00061-2","article-title":"Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): Two randomised, double-blind, placebo-controlled, phase 3 studies","volume":"401","author":"Sandborn","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1570","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.3390\/jcm12155014","article-title":"Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis","volume":"12","author":"Bencardino","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1575","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/jca.21631","article-title":"Efficacy and safety of granulocyte adsorption apheresis in elderly patients with ulcerative colitis","volume":"33","author":"Ito","year":"2018","journal-title":"Clin Apher"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1580","doi-asserted-by":"crossref","first-page":"771","DOI":"10.14309\/ajg.0000000000000210","article-title":"Immunomodulatory therapy does not increase the risk of cancaer in persons with inflammatory bowel disease and a history of extracolonic cancers","volume":"114","author":"Ma\u00f1osa","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1585","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cgh.2024.05.006","article-title":"Safety of Immunosuppression in a Prospective Cohort of Inflammatory Bowel Disease Patients With a HIstoRy of CancEr: SAPPHIRE Registry","volume":"23","author":"Itzkowitz","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1590","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ecco-jcc\/jjac187","article-title":"ECCO guidelines on inflammatory bowel disease and malignancies","volume":"17","author":"Gordon","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1595","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/apt.17520","article-title":"Patients with elderly onset inflammatory bowel disease have a decreased chance of initiation of all types of medications and increased risk of surgeries-A nationwide cohort study","volume":"58","author":"N\u00f8rg\u00e5rd","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1600","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.surg.2021.04.030","article-title":"Frailty is a stronger predictor than age for postoperative morbidity in Crohn's disease","volume":"170","author":"Wolf","year":"2021","journal-title":"Surgery"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1605","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ecco-jcc\/jjac129","article-title":"ECCO Topical review: Roadmap to optimal peri-operative care in IBD","volume":"17","author":"Sebastian","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1610","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/ecco-jcc\/jjab209","article-title":"Inflammatory Bowel diseases benefit from enhanced recovery after surgery (ERAS) protocol: A systematic review with practical implications","volume":"16","author":"Vigorita","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1615","first-page":"199","article-title":"Advancements in malnutrition in elderly inflammatory bowel disease patients","volume":"1","author":"Mao","year":"2023","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1620","doi-asserted-by":"crossref","first-page":"e158451","DOI":"10.1172\/JCI158451","article-title":"Metabolic changes in aging humans: Current evidence and therapeutic strategies","volume":"132","author":"Palmer","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1625","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3945\/an.115.011254","article-title":"Risk factors for malnutrition in older adults: A systematic review of the literature based on longitudinal Data","volume":"7","author":"Favaro-Moreira","year":"2016","journal-title":"Adv Nutr"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1630","first-page":"S15","article-title":"Association between food intake and oral health in elderly: SEPAHAN systematic review no","volume":"8","author":"Kazemi","year":"2011","journal-title":"8. Dent Res J"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1635","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fnagi.2018.00080","article-title":"Disease specific aspects of malnutrition in neurogeriatric patients","volume":"10","author":"Prell","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1640","doi-asserted-by":"crossref","first-page":"102395","DOI":"10.1016\/j.aprim.2022.102395","article-title":"Fragilidad en atenci\u00f3n primaria: diagn\u00f3stico y manejo multidisciplinar","volume":"54","author":"Acosta-Benito M\u00c1","year":"2022","journal-title":"Aten Primaria"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1645","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.clnu.2016.12.027","article-title":"ESPEN guideline: Clinical nutrition in inflammatory bowel disease","volume":"36","author":"Forbes","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1650","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.clnu.2022.12.004","article-title":"ESPEN guideline on Clinical Nutrition in inflammatory bowel disease","volume":"42","author":"Bischoff","year":"2023","journal-title":"Clin Nutr"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1655","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1660","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) \u201ccachexia-anorexia in chronic wasting diseases\u201d and \u201cnutrition in geriatrics\u201d","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clin Nutr"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1665","article-title":"ICD-10-International Classification of Diseases","year":"2021","journal-title":"Tenth Revision."},{"key":"10.1016\/j.gastrohep.2025.502529_bib1670","doi-asserted-by":"crossref","first-page":"e13033","DOI":"10.1002\/jgh3.13033","article-title":"Sarcopenia and frailty in inflammatory bowel disease: Emerging concepts and evidence","volume":"8","author":"Neelam","year":"2024","journal-title":"JGH Open"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1675","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s11255-015-1112-z","article-title":"Frailty phenotype and chronic kidney disease: A review of the literature","volume":"47","author":"Musso","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1680","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/hep.32157","article-title":"Frailty is associated with increased risk of cirrhosis disease progression and death","volume":"75","author":"Wang","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1685","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/s41430-021-00857-x","article-title":"Combination of sarcopenia and high visceral fat predict poor outcomes in patients with Crohn's disease","volume":"75","author":"Boparai","year":"2021","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1690","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41430-021-00953-y","article-title":"Sarcopenia assessed by computed tomography is associated with colectomy in patients with acute severe ulcerative colitis","volume":"76","author":"Ge","year":"2022","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1695","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/ejcn.2017.10","article-title":"Low muscle mass at initiation of anti-TNF therapy for inflammatory bowel disease is associated with early treatment failure: A retrospective analysis","volume":"71","author":"Holt","year":"2017","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1700","doi-asserted-by":"crossref","first-page":"582258","DOI":"10.3389\/fphys.2020.582258","article-title":"Crosstalk Between Skeletal Muscle and Immune System: Which Roles Do IL-6 and Glutamine Play?","volume":"11","author":"Rogeri","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1705","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/00365520601010115","article-title":"The insulin-like growth factor (IGF) system and its relation to infliximab treatment in adult patients with Crohn's disease","volume":"42","author":"Eivindson","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1710","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ghir.2006.10.003","article-title":"The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: Relations to disease activity and corticosteroid treatment","volume":"17","author":"Eivindson","year":"2007","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1715","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1016\/j.clnu.2021.02.007","article-title":"Association between malnutrition and stages of sarcopenia in geriatric rehabilitation inpatients: RESORT","volume":"40","author":"Verstraeten","year":"2021","journal-title":"Clin Nutr"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1720","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.3390\/nu12092820","article-title":"Nutritional intervention to prevent the functional decline in community-dwelling older adults: A systematic review","volume":"12","author":"Mareschal","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1725","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.clnu.2023.05.002","article-title":"Systematic review of sarcopenia in inflammatory bowel disease","volume":"42","author":"Fatani","year":"2023","journal-title":"Clin Nutr"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1730","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1016\/j.clnu.2020.01.001","article-title":"Sarcopenia and visceral obesity assessed by computed tomography are associated with adverse outcomes in patients with Crohn's disease","volume":"39","author":"Grillot","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1735","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jcsm.12048","article-title":"SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes","volume":"7","author":"Malmstrom","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1740","first-page":"1230e8","article-title":"Combined Patient-Generated Subjective Global Assessment and body composition facilitates nutritional support in inflammatory bowel disease: An ambulatory study in Shanghai","volume":"27","author":"Bian","year":"2018","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1745","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/MIB.0000000000001047","article-title":"Supplementation with 2000 IU of cholecalciferol is associated with improvement of trabecular bone mineral density and muscle power in pediatric patients with IBD","volume":"23","author":"Hradsky","year":"2017","journal-title":"Inflamm. Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1750","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/2050640620936383","article-title":"Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn's disease","volume":"8","author":"Seeger","year":"2020","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1755","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/apt.16002","article-title":"Randomised clinical trial: Combined impact and resistance training in adults with stable Crohn's disease","volume":"52","author":"Jones","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1760","unstructured":"Izquierdo M, G\u00f3mez M, Mart\u00ednez-Velilla N, Casas-Herrero \u00c1. Vivifrail: Programa de ejercicio f\u00edsico para prevenir la fragilidad y ca\u00eddas en personas mayores. Grupo de Investigaci\u00f3n en Ejercicio, Salud y Calidad de Vida (EJES), Universidad P\u00fablica de Navarra. Disponible en: https:\/\/vivifrail.com [consultado 20 Jun 2025]."},{"key":"10.1016\/j.gastrohep.2025.502529_bib1765","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: Chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1770","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/cells11030359","article-title":"Interconnections between Inflammageing and Immunosenescence during Ageing","volume":"11","author":"Teissier","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1775","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126709","article-title":"Characteristics of randomized controlled trials designed for elderly: A systematic review","volume":"10","author":"Broekhuizen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1780","first-page":"1390","volume":"25","author":"Kariyawasam","year":"2019","journal-title":"Comorbidities Rather Than Age Are Associated With the Use of Immunomodulators in Elderly-onset Inflammatory Bowel Disease Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1785","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/europace\/eut312","article-title":"Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: A nationwide study","volume":"16","author":"Kristensen","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1790","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S2468-1253(19)30173-6","article-title":"Comorbidities in inflammatory bowel disease: a call for action","volume":"4","author":"Argollo","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1795","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MCA.0000000000000899","article-title":"Major acute cardiovascular events in patients with inflammatory bowel disease","volume":"32","author":"Gill","year":"2021","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1800","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.14309\/ajg.0000000000002330","article-title":"Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission","volume":"118","author":"Yarur","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1805","article-title":"GLP-1 based therapies and disease course of inflammatory bowel disease","volume":"37p","author":"Villumsen","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1810","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12974-018-1382-3","article-title":"Bidirectional gut-brain-microbiota axis as a potential link between inflammatory bowel disease and ischemic stroke","volume":"15","author":"Zhao","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1815","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.gastha.2022.06.007","article-title":"The Risk of Type 2 Diabetes in Patients With Inflammatory Bowel Disease After Bowel Resections: A Nationwide Cohort Study","volume":"1","author":"Allin","year":"2022","journal-title":"Gastro Hep Adv"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1820","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/ecco-jcc\/jjaa136","article-title":"Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus","volume":"15","author":"Tseng","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1825","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.gastrohep.2023.12.008","volume":"47","author":"Domenech","year":"2024","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1830","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ueg2.12280","article-title":"European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism \/United European Gastroenterology guideline","volume":"10","author":"Bischoff","year":"2022","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1835","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000509544","article-title":"Malignancies in Inflammatory Bowel Disease","volume":"101","author":"Greuter","year":"2020","journal-title":"Digestion"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1840","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/j.gastro.2022.05.038","article-title":"Risk of Cancer in Inflammatory Bowel Diseases: Umbrella Review and Reanalysis of Meta-analyses","volume":"163","author":"Piovani","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1845","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1055\/s-0043-1771467","article-title":"The Interface between Inflammatory Bowel Disease, Neuroinflammation, and Neurological Disorders","volume":"43","author":"Hey","year":"2023","journal-title":"Semin Neurol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1850","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s10803-017-3409-5","article-title":"Association of Autism Spectrum Disorders and Inflammatory Bowel Disease","volume":"48","author":"Lee","year":"2018","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1855","first-page":"1","article-title":"Polypharmacy: definitions, measurement and stakes involved - review of the literature and measurement tests","volume":"204","author":"Mon\u00e9gat","year":"2014","journal-title":"Quest d\u2019\u00e9conomie la Sant\u00e9"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1860","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","article-title":"Adverse outcomes of polypharmacy in older people: systematic review of reviews","volume":"21","author":"Davies","year":"2020","journal-title":"J Am Med Dir Assoc."},{"key":"10.1016\/j.gastrohep.2025.502529_bib1865","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s12877-022-03279-x","article-title":"Prevalence and factors associated with polypharmacy: a systematic review and Meta-analysis","volume":"22","author":"Delara","year":"2022","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.gastrohep.2025.502529_bib1870","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.clinthera.2006.08.006","article-title":"Multidisciplinary Consensus Panel. Clinically important drug disease interactions and their prevalence in older adults","volume":"28","author":"Lindblad","year":"2006","journal-title":"Clin Ther."},{"key":"10.1016\/j.gastrohep.2025.502529_bib1875","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1111\/jgs.13153","article-title":"Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review","volume":"62","author":"Fried","year":"2014","journal-title":"J Am Geriatr Soc."},{"key":"10.1016\/j.gastrohep.2025.502529_bib1880","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40266-014-0163-7","article-title":"Medication non-adherence among elderly patients newly discharged and receiving polypharmacy","volume":"31","author":"Pasina","year":"2014","journal-title":"Drugs Aging."},{"key":"10.1016\/j.gastrohep.2025.502529_bib1885","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00228-014-1780-0","article-title":"Optimizing elderly pharmacotherapy: polypharmacy vs. undertreatment. Are these two concepts related?","volume":"71","author":"Blanco-Reina","year":"2015","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.gastrohep.2025.502529_bib1890","doi-asserted-by":"crossref","first-page":"1067.e1","DOI":"10.1016\/j.jamda.2016.08.019","article-title":"Polypharmacy and medication regimen complexity as risk factors for hospitalization among residents of long-term care facilities: a prospective cohort study","volume":"17","author":"Lalic","year":"2016","journal-title":"J Am Med Dir Assoc."},{"key":"10.1016\/j.gastrohep.2025.502529_bib1895","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.japh.2017.06.002","article-title":"Association between polypharmacy and death: a systematic review and meta-analysis","volume":"57","author":"Leelakanok","year":"2017","journal-title":"J Am Pharm Assoc."},{"key":"10.1016\/j.gastrohep.2025.502529_bib1900","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/fampra\/cml067","article-title":"Prevalence and predictors of polypharmacy among older primary care patients in Germany","volume":"24","author":"Junius-Walker","year":"2007","journal-title":"Fam Pract."},{"key":"10.1016\/j.gastrohep.2025.502529_bib1905","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210701","article-title":"Patterns of multimorbidity and polypharmacy in young and adult population: systematic associations among chronic diseases and drugs using factor analysis","volume":"14","author":"Menditto","year":"2019","journal-title":"PLoS One."},{"key":"10.1016\/j.gastrohep.2025.502529_bib1910","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/MEG.0000000000000891","article-title":"Chronic comorbidities associated with inflammatory bowel disease: prevalence and impact on healthcare costs in Switzerland","volume":"29","author":"B\u00e4hler","year":"2017","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2025.502529_bib1915","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/MIB.0000000000000620","article-title":"Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases","volume":"22","author":"Mikocka-Walus","year":"2016","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2025.502529_bib1920","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/apt.15076","article-title":"Comorbid immunemediated diseases in inflammatory bowel disease: a nation-wide population-based study","volume":"49","author":"Park","year":"2019","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2025.502529_bib1925","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/ajg.2011.271","article-title":"Inflammatory bowel disease of the elderly: Frequently asked questions [FAQs]","volume":"106","author":"Katz","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1930","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.crohns.2010.08.004","article-title":"IBD in the elderly population: results from a population-based study in Western Hungary, 1977-2008","volume":"5","author":"Lakatos","year":"2011","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1935","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2165\/11537340-000000000-00000","article-title":"Inflammatory bowel disease in the elderly","volume":"27","author":"Hussain","year":"2010","journal-title":"Drugs Aging"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1940","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1097\/MCG.0000000000001647","article-title":"Polypharmacy in Patients With Inflammatory Bowel Disease: Prevalence and Outcomes in a Single-center Series","volume":"56","author":"Mesonero","year":"2022","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1945","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.1365-2036.2005.02429.x","article-title":"Polypharmacy and Crohn's disease","volume":"21","author":"Cross","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1950","doi-asserted-by":"crossref","first-page":"496","DOI":"10.5217\/ir.2019.00050","article-title":"Polypharmacy is a risk factor for disease flare in adult patients with ulcerative colitis: A retrospective cohort study","volume":"17","author":"Wang","year":"2019","journal-title":"Intest Res"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1955","first-page":"1392","article-title":"Older age and steroid use are associated with increasing polypharmacy and potential medication interactions among patients with inflammatory bowel disease","volume":"21","author":"Parian","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1960","doi-asserted-by":"crossref","first-page":"374","DOI":"10.5455\/bcp.20160224101558","article-title":"Is depression a predictive factor for polypharmacy in elderly?","volume":"26","author":"Yuruyen","year":"2016","journal-title":"Bull Clin Psychopharmacol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1965","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/ibd\/izad244","article-title":"Inflammatory Bowel Disease in Adults and Elderly: The Use of Selected Non-IBD Medication Examined in a Nationwide Cohort Study","volume":"30","author":"Lund","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1970","article-title":"A comprehensive review of geriatric syndromes and assessment in older adults with inflammatory bowel diseases","volume":"11","author":"Calafat","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1975","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/DCR.0b013e31823d0ec5","article-title":"Dehydration is the most common indication for readmission after diverting ileostomy creation","volume":"55","author":"Messaris","year":"2012","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1980","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CEG.S120816","article-title":"Exercise in patients with Inflammatory bowel diseases: Current perspectives","volume":"11","author":"Engels","year":"2017","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1985","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1097\/MIB.0b013e318296ae5a","article-title":"The efficacy and methodological challenges of psycotehrapy for adults with inflammatory bowel disease: A review","volume":"19","author":"Knowles","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib1990","doi-asserted-by":"crossref","first-page":"942L 954","DOI":"10.1177\/2050640619852532","article-title":"Health-related quality of life in inflammatory bowel disease in a Danish population-based inception cohort","volume":"7","author":"Christiansen","year":"2019","journal-title":"United European Gastroenterol J."},{"key":"10.1016\/j.gastrohep.2025.502529_bib1995","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ibd.21346","article-title":"Anxiety and depression in patients with inflammatory bowel disease: Comparisons with chronic liver disease patients and the general population","volume":"17","author":"Hauser","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib2000","doi-asserted-by":"crossref","first-page":"e00572","DOI":"10.14309\/ctg.0000000000000572","article-title":"Social network diversity and the daily burden of inflammatory bowel disease","volume":"14","author":"Green-Highs","year":"2023","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib2005","article-title":"Position statement of the Spanish working group on Crohn's disease and ulcerative colitis on the use of telemedicine in inflammatory bowel disease [Article in English, Spanish]","volume":"502320","author":"Aguas","year":"2024","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib2010","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S2468-1253(19)30089-5","article-title":"The Influence of the Brain-Gut Axis in Inflammatory Bowel Disease and Possible Implications for Treatment","volume":"4","author":"Gracie","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib2015","doi-asserted-by":"crossref","first-page":"ii46","DOI":"10.1093\/ecco-jcc\/jjae067","article-title":"Considerations on Multimorbidity and Frailty in Inflammatory Bowel Diseases","volume":"18","author":"Carbery","year":"2024","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib2020","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.gastrohep.2022.03.004","volume":"45","author":"Riba","year":"2022","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib2025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.gastrohep.2023.05.004","volume":"47","author":"Machlab","year":"2024","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib2030","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.cgh.2020.08.010","article-title":"Frailty is independently associated with mortality and readmission in hospitalized patients with inflammatory bowel diseases","volume":"19","author":"Qian","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib2035","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1007\/s10620-020-06746-w","article-title":"Increasing prevalence of frailty and its association with readmission and mortality among hospitalized patients with IBD","volume":"66","author":"Faye","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2025.502529_bib2040","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1016\/j.cgh.2022.01.001","article-title":"Prevalence and implications of frailty in older adults with incident inflammatory bowel diseases: a nationwide cohort study","volume":"20","author":"Kochar","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502529_bib2045","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000528459","article-title":"The prevalence and factors that impact frailty in inflammatory bowel disease patients hospitalized in a tertiary hospital in China","volume":"41","author":"You","year":"2023","journal-title":"Dig Dis"},{"key":"10.1016\/j.gastrohep.2025.502529_bib2050","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/DCR.0000000000002524","article-title":"Conventional frailty index does not predict risk of postoperative complications in patients with IBD: A multicenter cohort study","volume":"66","author":"Rozich","year":"2023","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.gastrohep.2025.502529_bib2055","doi-asserted-by":"crossref","DOI":"10.1177\/17562848231194395","article-title":"Handgrip strength and risk of malnutrition are associated with an increased risk of hospitalizations in inflammatory bowel disease patients","volume":"16","author":"Bedard","year":"2023","journal-title":"Therapy Adv Gastroenterol"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570525003991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570525003991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T09:23:31Z","timestamp":1766395411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570525003991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":210,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0210570525003991"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2025.502529","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Documento de posicionamiento de GETECCU sobre fragilidad, edad avanzada y enfermedad inflamatoria intestinal","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2025.502529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"502529"}}